Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Cell/Gene Therapies’ Unique Attributes Set Them Apart, Say Comments on Draft Guidance

  • Post author:PacConAdmin
  • Post published:March 27, 2024
  • Post category:Uncategorized

Comments filed on the FDA’s proposed guidance on potency assurance for cellular and gene therapy (CGT) products reflect the intricacies that set these treatments apart from drug interventions. Source: Drug…

Continue ReadingCell/Gene Therapies’ Unique Attributes Set Them Apart, Say Comments on Draft Guidance

EC Seeks Comments on Benefit-Risk of Phthalates in Medical Devices

  • Post author:PacConAdmin
  • Post published:March 27, 2024
  • Post category:Uncategorized

Comments are sought by the Scientific Committee on Health, Environmental and Emerging Risks on an update of the European Commission guidelines on the presence of phthalates in medical devices. Source:…

Continue ReadingEC Seeks Comments on Benefit-Risk of Phthalates in Medical Devices

High Levels of Lidocaine in OTC Numbing Products Prompts Six FDA Warning Letters

  • Post author:PacConAdmin
  • Post published:March 27, 2024
  • Post category:Uncategorized

Six manufacturers of numbing gels, creams and sprays marketed to relieve pain from cosmetic procedures have received FDA Warning Letters for concentrations of lidocaine in their products in excess of…

Continue ReadingHigh Levels of Lidocaine in OTC Numbing Products Prompts Six FDA Warning Letters

FDA Guidance Outlines Procedures for BA, BE Testing Samples Handling, Retention

  • Post author:PacConAdmin
  • Post published:March 26, 2024
  • Post category:Uncategorized

The FDA’s guidance on the quantity of bioavailability (BA) and bioequivalence (BE) testing samples to be retained by NDA applicants and contract research organizations (CRO) contains both draft and final…

Continue ReadingFDA Guidance Outlines Procedures for BA, BE Testing Samples Handling, Retention

Retention of Bioresearch Investigators a Major Issue for FDA, GAO Report Says

  • Post author:PacConAdmin
  • Post published:March 26, 2024
  • Post category:Uncategorized

The recruitment and retention of Bioresearch Monitoring (BIMO) program investigators has been a thorn in the side of the FDA that’s negatively impacted trial inspections, a Government Accountability Office (GAO)…

Continue ReadingRetention of Bioresearch Investigators a Major Issue for FDA, GAO Report Says

Second Consultation Opens for EMA Draft Guidance on Advanced Therapy Products

  • Post author:PacConAdmin
  • Post published:March 26, 2024
  • Post category:Uncategorized

Closing on May 31, the European Medicines Agency (EMA) has opened a second consultation for its guideline on requirements for investigational advanced therapy medicinal products (ATMP) in clinical trials. Source:…

Continue ReadingSecond Consultation Opens for EMA Draft Guidance on Advanced Therapy Products

New Quantitative Medicine Center of Excellence Established by CDER

  • Post author:PacConAdmin
  • Post published:March 26, 2024
  • Post category:Uncategorized

The FDA on Monday announced creation of the new Quantitative Medicine (QM) Center of Excellence to facilitate and coordinate the continuous evolution and consistent application of QM across CDER. Source:…

Continue ReadingNew Quantitative Medicine Center of Excellence Established by CDER

New Ban of Electrical Stimulation Devices Proposed Rule Issued by FDA

  • Post author:PacConAdmin
  • Post published:March 25, 2024
  • Post category:Uncategorized

In a step rarely taken by the agency, the FDA today has proposed a ban of electrical stimulation devices (ESD) intended to reduce or stop self-injurious or aggressive behavior because…

Continue ReadingNew Ban of Electrical Stimulation Devices Proposed Rule Issued by FDA

Quick Notes: Drug News — March 25, 2024

  • Post author:PacConAdmin
  • Post published:March 25, 2024
  • Post category:Uncategorized

This edition of Quick Notes looks at the first nonsteroidal oral med for Duchenne muscular dystrophy, expanded indications for a cardiovascular risk reduction drug, an oncology approval, two Complete Response…

Continue ReadingQuick Notes: Drug News — March 25, 2024

Expanding, Embracing Sterilization Standards Endorsed in FDA Webinar

  • Post author:PacConAdmin
  • Post published:March 25, 2024
  • Post category:Uncategorized

A week following the EPA’s announced new rules for facilities emitting cancer-causing ethylene oxide (EtO), FDA officials urged consensus standards be developed and broadly accepted for medical device sterilization protocols…

Continue ReadingExpanding, Embracing Sterilization Standards Endorsed in FDA Webinar
  • Go to the previous page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 143
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company